NG
Neurogene Inc.
NGNE · NASDAQ
$38.13 -0.96% (-$0.37)
1M +4.32%
Market Cap $602.5M
P/E Ratio -
Div. Yield -
ROE 45.11%
Bulios Fair Price
$19.76
48.2% downside
Trenutna cena
$38.13
Podcenjeno Poštena vrednost Precenjeno
Po podatkih Bulios Fair Price je delnica NGNE trenutno precenjena glede na svojo tržno ceno. Kako deluje?
Bulios Fair Price je ocena poštene vrednosti delnice iz Buliosovega modela vrednotenja. Je vhod za vašo lastno analizo, ne naložbeno priporočilo. Kako deluje?
Piotroski F-Score Weak
1/9Valuation
70 /100
Cheap P/B 2.77x
EV/FFO N/A
P/E N/A
Growth
100 /100
Growing Book val. growth 39.00%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 45.47%
ROIC 53.72%
Asset turnover 0.00x
Debt
69 /100
Low Int. coverage -55,554.00x
Debt/Equity 0.04x
Current ratio 10.64x
Stability
21 /100
Unstable Profitable years 0
Beta 1.95x
EPS volatility 43.06%
Bulios Scoring opisuje kakovost in preteklost podjetja, ne prihodnjega donosa. Visok rezultat ni nakupni signal. Izvedite več
Vprašajte StockBota o NGNE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Rachel L. McMinn
Employees
131
Headquarters
New York City
Prihajajoči dogodki
12 NOV.
Earnings
Upcoming earnings report